Cardiotoxic effects of 5-fluorouracil in the guinea pig.

In order to search into the underlying mechanisms of ECG changes suggestive of ischemia observed in humans and in rabbits after administration of 5-fluorouracil (5-FU), experiments were performed in anesthetized open-chest guinea pigs. The substance produced similar ECG changes in this species as well, after a rather long latent period of around 3 hours after intravenous administration. The incidence of ECG abnormality in animals given 60 mg/kg was 7/7, while that in animals given 30 mg/kg was 4/9. with 10-20 mg/kg, ECG changes were not observed during an experimental period as long as 5 hours. Associated with these ECG changes, a depletion of the high-energy phosphate compounds of the ventricular myocardium was observed. Analysis of tricarboxylic acid cycle (TCA cycle) intermediates revealed an accumulation of citrate within the myocardium, suggesting a malfunction of TCA cycle resulting from an inhibition of aconitase by fluorocitrate, as a cause of depletion of the high-energy phosphates. It is highly probable that the accumulation of citrate was due to the formation of fluoroacetate, an inhibitor of aconitase, from 5-FU via alpha-fluoro-beta-alanine, a major degradation product of 5-FU, for it is known that beta-alanine is usually converted to acetate.

[1]  W. Mommaerts,et al.  An estimation of the true inorganic phosphate content of frog sartorius muscle. , 1961, The Journal of biological chemistry.

[2]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. II. Effects on transplanted tumors. , 1958, Cancer research.

[3]  I. Mccoll,et al.  5-FLUOROURACIL AND ANGINA , 1975, The Lancet.

[4]  R. Passmore,et al.  BIOCHEMICAL LESIONS AND LETHAL SYNTHESIS , 1964 .

[5]  D. E. Atkinson,et al.  Adenosine triphosphate conservation in biosynthetic regulation. Escherichia coli phosphoribosylpyrophosphate synthase. , 1967, The Journal of biological chemistry.

[6]  J. Parker,et al.  Determination of myocardial acid-soluble adenine nucleotides on anion-exchange thin layers. , 1972, Journal of chromatography.

[7]  A. Gilman,et al.  STUDIES ON THE PHARMACOLOGY OF FLUOROACETATE , 1946 .

[8]  G. M. Walton,et al.  Adenosine triphosphate conservation in metabolic regulation. Rat liver citrate cleavage enzyme. , 1967, The Journal of biological chemistry.

[9]  C. H. Fiske,et al.  THE COLORIMETRIC DETERMINATION OF PHOSPHORUS , 1925 .

[10]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14. , 1960, The Journal of biological chemistry.

[11]  K. Kolarić,et al.  Letter: Cardiotoxicity of 5-fluorouracil (NSC-19893) , 1975, Cancer chemotherapy reports.

[12]  H. Koenig,et al.  Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate. , 1970, Archives of neurology.

[13]  R. Peters Biochemical lesions and lethal synthesis , 1963 .

[14]  L. Katz,et al.  The Relation of Cardiac Effort to Myocardial Oxygen Consumption and Coronary Flow , 1958, Circulation research.

[15]  C. Heidelberger,et al.  Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds , 1957, Nature.

[16]  R. Bing,et al.  Oxidation Reduction in Heart Muscle: Theoretical and Clinical Considerations , 1962, Circulation.